Chan, J. A., Strosberg, J. R., Yoo, C., Singh, S., Wang, Z., Sierra, L., Bolotin, E., Capdevila, J. (2026). Zanzalintinib versus everolimus in patients with previously treated advanced neuroendocrine tumors: The phase 2/3, randomized STELLAR-311 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps647